Thursday, January 28, 2010

4 Signs of Sleep Deprivation in Teens


4 Signs of Sleep Deprivation in Teens

Signs of insufficient sleep may include the following:
  1. Memory lapses and inattention
  2. Irritability, depressed mood, being overly emotional
  3. Falling asleep spontaneously during quiet times
  4. Needing catch-up slee on the weekends

Obstructive sleep apnea (OSA), a form of sleep-disordered breathing


OVERVIEW

Obstructive sleep apnea (OSA), a form of sleep-disordered breathing, encompasses a spectrum of breathing disturbances caused by narrowing of the upper airway. Zuid Afrikaans Sleep Centre treats a number of OSA patients each year and is a leader in research to better understand the disorder and develop new treatments.

Diagnosis

Dr Yacoob Omar Carrim's approach to diagnosis of OSA is based on advanced patient testing, examination and analysis of symptoms.

Treatment

Patients treated for OSA benefit from the combined expertise of top specialists working together across the fields of sleep medicine, otorhinolaryngology (ear, nose and throat), cardiology, orthodontics, oral surgery, endocrinology, and nursing. Each patient is unique and specialists combine their expertise to develop the best treatment plan possible.

Monday, January 18, 2010

Periodic Limb Movements during Sleep

Periodic Limb Movements during Sleep

Periodic limb movement (PLM) disorder is unique in that the movements occur during sleep. Most other movement disorders manifest during wakefulness. The condition is remarkably periodic, and the movements may cause poor sleep and subsequent daytime somnolence. PLM disorder may occur with other sleep disorders and is related to, but not synonymous with, restless leg syndrome (RLS), a less specific condition with sensory features that manifest during wakefulness. The majority of patients with RLS have PLM disorder, but the reverse is not true. Treatment involves either dopaminergic medication in an attempt to modify activity of the subcortical motor system or, more commonly, sedative medications to allow uninterrupted sleep. Many new agents are proving efficacious for treatment as well.

Symonds first described PLM disorder in 1953. The original name, "nocturnal myoclonus," does not describe the condition accurately, since the movements are slower than are those of myoclonus. The original name seldom is used today.


The etiology of the primary form of PLM disorder is uncertain. Suprasegmental disinhibition of the descending inhibitory pathways may be a factor. Because the etiology is not clear, treatment is primarily symptomatic and does not modify the disease. Studies differ regarding the frequency of polyneuropathy in cases of PLM disorder. Martinez-Mena and Pastor found that only 1 of 9 patients had signs of neuropathy.

The secondary forms of PLM disorder may be due to diabetes mellitus, spinal cord tumor, sleep apnea syndrome, narcolepsy, uremia, or anemia. Many authors report an association between attention deficit hyperactivity disorder (ADHD) and PLM disorder. Antidopaminergic, dopaminergic, or tricyclic drug therapy or cessation of treatment with barbiturates or benzodiazepines may initiate the syndrome as well. Voderholzer and colleagues noted an increased incidence of periodic limb movements during sleep in patients with Gilles de la Tourette syndrome. However, the authors emphasized that the different responses to pharmacological treatments are evidence against a pathophysiological relationship between PLM disorder and Gilles de la Tourette syndrome.

The presenting symptom may be stereotyped periodic limb movements that cause awakening during the night, but often the presenting complaint is poor sleep and daytime somnolence. Haba-Rubio et al report that sleep changes induced by periodic limb movements during sleep (PLMS) are associated with decreased physical and psychological fitness on awakening.

Occasionally, a bed partner may provide the history of limb movements.
Nozawa and colleagues studied arousal index and movement index in PLM disorder and noted that the sleep-wake disorders associated with PLM relate to threshold of awakening.
Leg movements are stereotyped and involve one or both limbs.

The movement simulates triple flexion with leg flexion, ankle dorsiflexion, and great toe extension; it lasts approximately 2 seconds and thus is not consistent with the rapid jerk that defines true myoclonus.
The periodicity ranges from 20-40 seconds with a variable duration. The movements are said to occur mainly in non?rapid eye movement (REM) sleep.

Restless Legs Syndrome

Restless Legs Syndrome

The term restless legs syndrome (RLS) was used initially in the mid-1940s by Swedish neurologist Karl A. Ekbom to describe a disorder characterized by sensory symptoms and motor disturbances of the limbs, mainly during rest. However, early descriptions date back to the 17th century. It is recognized now as a neurologic movement disorder of the limbs, often associated with a sleep complaint. Patients with RLS have a characteristic difficulty in trying to depict their symptoms; they may report sensations such as an almost irresistible urge to move the legs, which are not painful but are distinctly bothersome; this can lead to significant physical and emotional disability. The sensations usually are worse during inactivity and often interfere with sleep, leading to walking discomfort, chronic sleep deprivation, and stress. Once correctly diagnosed, RLS can usually be treated effectively by relieving symptoms; in some secondary cases, it can even be cured.


Pathogenesis of RLS is unclear. Ekbom originally proposed that it was mainly the result of accumulation of metabolites in the legs because of venous congestion. Peripheral nerve abnormalities also have been proposed, but no associated structural changes in nerve endings have been identified.

RLS also has been linked to dopaminergic or opiate abnormalities. Centrally acting dopamine receptor antagonists reactivate symptoms when given to patients with the syndrome. Results of single-photon emission computed tomography (SPECT) have suggested deficiency of dopamine D2 receptors. Sympathetic hyperactivity also has been implicated on the basis of observations that sympathetic nerve blockade relieves periodic limb movements of sleep and that alpha-adrenergic blockers improve symptoms of RLS. Studies also have suggested possible underactivity of the serotonin and gamma-aminobutyric acid (GABA) neurotransmitter systems.

The severity of symptoms in patients with RLS ranges from mild to intolerable. Although patients experience the sensations in their legs, they also may occur in the arms or elsewhere. RLS symptoms are generally worse in the evening and night and less severe in the morning. While RLS may present early in adult life with mild symptoms, usually by age 50 it progresses to daily severe disruption of sleep leading to decreased daytime alertness. RLS is associated with reduced quality of life in cross-sectional analysis.

A childhood-onset restless legs syndrome has also been described. A study published in Dec 2004 by Kotagal and Silber concluded that iron deficiency and a strong family history were characteristic of this childhood-onset presentation.

Insomnia

Insomnia

Insomnia is the most common sleep complaint. It is a perception that sleep quality is inadequate or non-restorative, despite the adequate opportunity to sleep. That insomnia is a symptom, not a disease, is important to note; it is associated with a variety of medical, psychiatric, and sleep disorders. A comprehensive history and physical examination are essential to determine the etiology of the insomnia.

The complaint of insomnia encompasses many sleep problems. These include difficulty falling asleep, sleeping too lightly, being easily disrupted with multiple spontaneous awakenings, or early morning awakenings with inability to fall back asleep. The timing of insomnia is important in determining its etiology. Therefore, having each patient define what he or she means by insomnia is essential.

To be considered a disorder, the complaint of insomnia should be accompanied by distress and/or impairment in daytime functioning.


On the basis of duration, insomnia is commonly divided into the following 3 types:

Transient insomnia lasts up to 1 week and often is referred to as adjustment sleep disorder because it most often is caused by an acute situational stress, such as a new job, upcoming deadline, or exam. It often recurs with new or similar stresses.
Short-term insomnia lasts for 1-6 months and is usually associated with more persistent stressful situational (death or illness of a loved one) or environmental (noise) factors.
Chronic insomnia is any insomnia lasting more than 6 months and is associated with a wide variety of disorders.
Insomnia usually results from an interaction of biological, physical, psychological, and environmental factors.

Although transient insomnia can occur in any person, chronic insomnia appears to develop only in a subset of patients who may have predisposing factors. Evidence for this theory includes the following:

When compared to control subjects, individual with insomnia (1) have higher rates of depression and anxiety, (2) score higher on scales of arousal, (3) have longer daytime sleep latency, (4) have an increased 24-hour metabolic rate, (5) have more night-to-night variability in their sleep, and (6) may have more beta EEG activity (an EEG pattern seen during memory processing/performing tasks) at sleep onset.
In experimental models of insomnia, control subjects deprived of sleep do not demonstrate the same abnormalities in metabolism, daytime sleepiness, and personality as persons with insomnia.
In an experimental model of giving control subjects caffeine, causing a state of hyperarousal, the control subjects did have changes in metabolism, daytime sleepiness, and personality similar to those seen in individuals with insomnia.
These results support a theory that insomnia is a manifestation of hyperarousal. In other words, the poor sleep may not itself be the cause of the daytime dysfunction but merely the nocturnal manifestation of a general disorder of hyperarousability.

Therefore, chronic insomnia is believed to primarily occur in patients with predisposing factors. These factors may cause the occasional night of poor sleep, but in general, the patient sleeps well until the occurrence of a precipitating event, such as death or other life stress. Then, acute insomnia develops. If poor sleep habits or other perpetuating factors occur, chronic insomnia develops despite the removal of the precipitating factor.

As stated previously, insomnia is a symptom; an accurate differential diagnosis is essential for the proper management of this complaint in any given patient.

Transient and short-term insomnia: Etiologies can be divided into 2 broad categories, as follows:

Environmental - Unfamiliar or unconducive sleep environment due to factors such as too much noise or light, extremes of temperature, or poor bed
Stress - Primarily life events such as new job or school, deadlines or exams, or death of a relative or close friend
Chronic insomnia: Differential diagnosis is broader and includes the following categories:

Medical disorders - Include chronic pain syndromes from any cause (eg, arthritis, cancer), advanced COPD, chronic renal disease (especially if on hemodialysis), chronic fatigue syndrome, and fibromyalgia
Neurologic disorders - Include Parkinson disease and other movement disorders, as well as headache syndromes, particularly cluster headaches, which frequently are triggered by sleep
Psychiatric disorders - Most chronic psychiatric disorders
Depression most commonly is associated with early morning awakenings and inability to fall back asleep; studies also have shown that insomnia can lead to depression. (The presence of insomnia for longer than 1 year is associated with an increased risk of depression.)
Schizophrenia and the manic phase of bipolar illness frequently are associated with sleep-onset insomnia.
Anxiety disorders (including nocturnal panic disorder and posttraumatic stress disorder) are associated with both sleep-onset and sleep-maintenance complaints.
Drug-related insomnia: Sleep disruption is common with excessive use of stimulants, alcohol, or sedative-hypnotics.
Primary sleep disorders

Restless leg syndrome (RLS)/periodic limb movement disorder (PLMD) is a sleep disorder characterized by unpleasant physical sensations in the legs, often described as a motor restlessness; relief of symptoms through movement, with worsening in a recumbent position; and occurrence only in the evening, primarily at bedtime. It is frequently relieved by movement (in the case of RLS) and is usually (but not necessarily) associated with frequent and rhythmic leg kicking once asleep (in the case of PLMD). If RLS is predominant, sleep-onset insomnia is the rule; if PLMD is predominant, sleep-maintenance insomnia or daytime hypersomnolence is more likely.
In obstructive sleep apnea, a minority of patients complain of insomnia rather than hypersomnolence. They frequently complain of multiple awakenings or sleep-maintenance difficulties.
Circadian rhythm disorders, such as sleep phase advance (patient goes to bed early and rises early) and sleep phase delay (patient goes to bed late and rises late) syndromes can present as insomnia when the patient wants to either stay in bed later or go to bed earlier but cannot and then believes he or she has a problem sleeping. Shift workers also frequently have problems with insomnia, particularly when they want to sleep during the day.
Primary insomnia: If all the disorders already discussed have been ruled out, the patient has primary insomnia. Most primary insomnia is psychophysiologic insomnia; rarely, primary insomnia is caused by idiopathic insomnia (long-standing insomnia beginning in childhood without antecedent psychiatric or medical trauma) or sleep state misperception (insomnia with objective evidence of a sleep disorder).

Psychophysiologic insomnia is a disorder of somatized tension and learned sleep-preventing associations resulting in a complaint of insomnia and daytime fatigue.
Psychophysiologic insomnia begins with a prolonged period of stress in a person with previously adequate sleep. The patient responds to stress with somatized tension and agitation, causing physiologic arousal. The bedroom and/or sleep routine becomes associated with frustration and arousal; poor sleep hygiene follows.
In a normal sleeper, as the initial stress abates, the bad sleep habits are extinguished gradually, as they are not reinforced. However, in a sleeper with a tendency toward occasional poor sleep nights, bad habits are reinforced, the individual "learns" to worry about his or her sleep, and chronic insomnia follows.
History in these patients frequently reveals excessive daily worries about not being able to fall asleep, evidence of trying too hard to sleep with apprehension if unable to fall asleep, an ability to fall asleep during monotonous pursuits (such as watching TV or reading) and in inappropriate situations (at a lecture or while driving) but not when desired, improvement of sleep in unusual sleep environments, and increased agitation and muscle tension prior to bed.

Obstructive sleep apnea-hypopnea (OSAH)

Obstructive Sleep Apnea

Obstructive sleep apnea-hypopnea (OSAH) is characterized by recurrent episodes of upper airway collapse and obstruction during sleep. These episodes of obstruction are associated with recurrent oxyhemoglobin desaturation and arousals from sleep. Obstructive sleep apnea-hypopnea syndrome (OSAHS) is a term frequently used when this is associated with excessive daytime sleepiness. Despite being a common disease, OSAHS is unrecognized by most primary care physicians (an estimated 80% of OSAHS cases in the United States are not diagnosed).

The upper airway is a compliant tube and is therefore subject to collapse. The majority of patients with OSAHS demonstrate upper airway obstruction, either at the level of the soft palate (nasopharynx) or at the level of the tongue (oropharynx). Recent research indicates that both anatomic and neuromuscular factors are important. Anatomic factors, such as enlarged tonsils, macroglossia, or abnormal positioning of the maxilla and mandible, decrease the cross-sectional area of the upper airway and/or increase the pressure surrounding the airway, both of which predispose the airway to collapse.


Upper airway neuromuscular activity, including reflex activity, decreases with sleep, and this decrease may be more pronounced in patients with OSAHS. Reduced ventilatory motor output to upper airway muscles is believed to be the critical initiating event leading to upper airway obstruction; this effect is most pronounced in patients with an upper airway predisposed to collapse for anatomic reasons.

Central breathing instability has been well established to contribute to the development of central sleep apnea, particularly in patients with severe congestive heart failure (Leung, 2001; Xie, 2002; Xie, 1995). Some evidence indicates that central breathing instability also contributes to the development of OSAHS. First, evidence of upper airway obstruction in the absence of ventilatory motor output (central sleep apnea) has been observed (Badr, 1995). Second, reduction in pharyngeal dilator activity has been associated with periodic breathing (Hudgel, 1987; Warner, 1987; Onal, 1986) and hypocapnia in subjects with evidence of inspiratory flow limitation (IFL) (Badr, 1997). Third, men have been shown to be more susceptible to the development of central sleep apnea and have a decreased responsiveness to carbon dioxide than woman (Zhou, 2000); these findings are consistent with the increased prevalence of OSAHS in men.

Retrospective data indicate that mortality rate is higher in patients with an apnea-hypopnea index [AHI] greater than 20 per hour than in those with an AHI less than 20 per hour. Groups treated with tracheostomy or nasal continuous positive airway pressure (CPAP), however, had no premature deaths. Since nasal CPAP became the standard of treatment, the effect of OSAHS on mortality rates has not been re-examined in a large-scale study.

Systemic hypertension is observed in 50-70% of patients with OSAHS. Several large cross-sectional studies have demonstrated that OSAHS is a risk factor for developing hypertension independent of obesity, age, alcohol intake, and smoking (Hla, 1994; Nieto, 2000). More recently, people in the Wisconsin Cohort Study were prospectively monitored for the development of hypertension. The investigators found a dose-response relationship between the degree of OSAHS and the presence of hypertension 4 years later (odds ratio 2.03 for apnea-hypopnea index [AHI] 5-15 and 2.89 for AHI >15) independent of confounding variables. Several small studies have shown small reductions in blood pressure when nasal CPAP is used in the treatment of OSAHS, though whether it was systolic, diastolic, or mean pressure that was lowered varied by study. No definitive study has demonstrated that treating OSAHS with nasal CPAP lowers the blood pressure on a long-term basis.

Relationship to the metabolic syndrome: The metabolic syndrome is now recognized as an important contributor to the development of atherosclerosis and cardiovascular disease. As defined, a patient with the metabolic syndrome has increased fasting glucose levels, increased blood pressure, lipid abnormalities, and obesity. Evidence of pro-inflammatory and oxidative stress also exists in these patients. Growing evidence suggests that OSAHS may contribute to the metabolic derangements that characterize the metabolic syndrome.

Hypertension: The relationship between OSAHS and hypertension is outlined above.
Insulin resistance: Multiple studies have shown that patients with OSAHS have increased glucose levels and increased insulin resistance (Ip, 2002; Punjabi, 2002; Punjabi, 2004). The most recent study was from the Sleep Heart Health Study (Punjabi, 2004). In this study of 2000 research subjects, the prevalence of diabetic 2-hour glucose tolerance values rose from 9.3% in the group with an AHI less than 5 to 15% in the group with an AHI greater than 15. The odds ratio for having an abnormal glucose tolerance test was 1.44 (p<0.0001) for the group with an AHI greater than 15; insulin resistance was also highest in this group. Correlations were also noted for the degree of oxygen desaturation at night, indicating that the OSAHS may contribute to insulin resistance as a result of the hypoxemia that occurs with the syndrome.
Oxidative stress: OSAHS has been associated with increased production of reactive oxygen species (Dyugovskaya, 2002) and other oxidative stress biomarkers (Lavie, 2004).
Vasodilator responses: OSAHS has been associated with decreased production of nitric oxide (Ip, 2000). Several studies have shown impaired vasodilator responses, as measured by either flow-mediated dilatation (Ip, 2004) or reactive hyperemic blood flow (Imadojemu, 2002) techniques. Impaired flow-mediated dilatation was found to best correlated with the degree of oxygen desaturation in an epidemiologic cohort study (Nieto, 2004).
Note that for most of these abnormalities, evidence from studies with small numbers of subjects suggests that CPAP partially reverses the metabolic abnormality that is the focus of the study (ie, CPAP decreased insulin resistance, decreased lipid peroxidation, increased vasodilator responses).
A large epidemiologic study (the Sleep Heart Health Study) is presently being conducted to provide more definitive data regarding the relationship between sleep apnea and cardiovascular morbidity. Initial findings from the SHHS indicate that a relationship exists between severe OSAHS and an increased risk of coronary artery disease, congestive heart failure, and stroke (Shahar, 2001). This study is ongoing to determine if the presence of OSAHS is associated with the development of cardiovascular morbidity.

A recent study found that OSAHS was associated with an increased risk of sudden death between the hours of midnight and 6 am, as compared to the general population (sudden death more common between 6 am and noon) (Gami, 2005).

Recent evidence indicates that OSAHS is not an independent risk factor for the development of pulmonary hypertension in the absence of other lung disease, as evidenced by the presence of daytime hypoxemia, hypercapnia, or obstructive airways disease.

Sleep Tips

Sleep Tips

Paying attention to good sleep hygiene is the most important thing you can do to maintain good sleep.

Do:

Go to bed at the same time each day.
Get up from bed at the same time each day.
Get regular exercise each day, preferably in the morning. There is good evidence that regular exercise improves restful sleep. This includes stretching and aerobic exercise.
Get regular exposure to outdoor or bright lights, especially in the late afternoon.
Keep the temperature in your bedroom comfortable.
Keep the bedroom quiet when sleeping.
Keep the bedroom dark enough to facilitate sleep.
Use your bed only for sleep and sex.
Take medications as directed. Its is often helpful to take prescribed sleeping pills one hour before bedtime, so they are causing drowsiness when you lie down, or 10 hours before getting up, to avoid daytime drowsiness
Use a relaxation exercise just before going to sleep.
Muscle relaxation, imagery, massage, warm bath, etc.
Keep your feet and hands warm. Wear warm socks and/or mittens or gloves to bed.


Don't:

Exercise just before going to bed.
Engage in stimulating activity just before bed, such as playing a competitive game, watching an exciting program on television or movie, or having an important discussion with a loved one.
Have caffeine in the evening (coffee, many teas, chocolate, sodas, etc.)
Read or watch television in bed.
Use alcohol to help you sleep.
Go to bed too hungry or too full.
Take another person's sleeping pills.
Take over-the-counter sleeping pills, without your doctor's knowledge. Tolerance can develop rapidly with these medications. Diphenhydramine (an ingredient commonly found in over-the-counter sleep medications) can have serious side effects for elderly patients.
Take daytime naps.
Command yourself to go to sleep. This only makes your mind and body more alert.
If you lie in bed awake for more than 20-30 minutes, get up, go to a different room (or different part of the bedroom), participate in a quiet activity (e.g. non-excitable reading or television), then return to bed when you feel sleepy. Do this as many times during the night as needed

Normal Sleep

Normal Sleep:

Normal sleep is divided into non?rapid eye movement (NREM) and rapid eye movement (REM) sleep. The stages of sleep are stage I (light sleep), stage II, stages III and IV (deep or delta-wave sleep), and REM sleep; NREM sleep comprises stages I-IV. Sleep is an active process that cycle at an ultradian rhythm of about 90 minutes.

Waking usually transitions into NREM sleep. REM follows NREM sleep and occurs 4-5 times during a normal 8- to 9-hour sleep period. The first REM period of the night may be less than 10 minutes in duration, while the last may exceed 60 minutes.

For the purpose of analysis, overnight sleep has been divided into 3 equal time periods: sleep in the first third of the night, which comprises the highest percentage of NREM; sleep in the middle third of the night; and sleep in the last third of the night, the majority of which is REM. Awakening after a full night's sleep is usually from REM sleep

Sleep in adults

In adults, sleep of 8-8.4 hours is considered fully restorative. In some cultures, total sleep often is divided into an overnight sleep period of 6-7 hours and a mid-afternoon nap of 1-2 hours.

Stage I is considered a transition between wake and sleep. It occurs upon falling asleep and during brief arousal periods within sleep and usually accounts for 5-10% of total sleep time. Stage II occurs throughout the sleep period and represents 40-50% of total sleep time. Stages III and IV delta sleep occur mostly in the first third of the night. They are distinguished from each other only by the percentage of delta activity and represent up to 20% of total sleep time. REM represents 20-25% of total sleep time.


Sleep in infants

Infants have an overall greater total sleep time than any other age group; their sleep time can be divided into multiple periods. In newborns, the total sleep duration in a day can be 14-16 hours.

Over the first several months of life, sleep time decreases; by age 5-6 months, sleep consolidates into an overnight period with at least 1 nap during the day. REM sleep in infants represents a larger percentage of the total sleep at the expense of stages III and IV. Until age 3-4 months, newborns transition from wake into REM sleep. Thereafter, wake begins to transition directly into NREM.

Overall, electrocortical recorded voltage remains high during sleep, as it does during periods of wakefulness. Sleep spindles begin appearing in the second month of life with a density greater than that seen in adults. After the first year, the spindles begin decreasing in density and progress toward adult patterns. K-complexes begin by the sixth month of life.



Sleep in elderly persons

In elderly persons, the time spent in stages III and IV sleep decreases by 10?15% and the time in stage II increases by 5% compared to young adults, representing an overall decrease in total sleep duration. Latency to fall asleep and the number and duration of overnight arousal periods increase. Thus to have a fully restorative sleep, the total time in bed must increase. If the elderly person does not increase the total time in bed, complaints of insomnia and chronic sleepiness may occur. Sleep fragmentation results from the increase in overnight arousals and may be exacerbated by the increasing number of geriatric medical conditions, including sleep apnea, musculoskeletal disorders, and cardiopulmonary disease.

Sleep Disorders in Pregnancy and the Postpartum Period

Sleep Disorders in Pregnancy and the Postpartum Period
Pregnancy is associated with a host of physical and emotional changes. Physical changes include morning sickness, body aches including back pain, heartburn and of course foetal movement. Emotional changes include a huge range including anxiety, fear and depression. Emotions can swing wildly. According to a National Sleep Foundation poll as well as other research, 78% of women experience more disruption of sleep than they normally experience. These changes vary with the stage of pregnancy:
In the first trimester there are high levels of progesterone. This may be associated with increased sleepiness. Some of the physical changes may also disrupt night time sleep, leading to further increases in daytime sleepiness.

The second trimester usually has less severe disruption of sleep than earlier or later stages, but still not normal quality sleep.

The third trimester is associated with the most significant changes in sleep. The physical changes of pregnancy are their greatest and include general discomfort, increased nocturnal urination, heartburn, back pain and nasal congestion. Studies have suggested that virtually all women have some disruption of their sleep in the third trimester.

In addition to the disruption of sleep that is a consequence of the physical and hormonal changes, certain specific sleep problems may also occur in pregnancy.

Because of the increased weight and the swelling of tissues that occurs in pregnancy, many women have the onset of snoring for the first time in pregnancy. If the airway obstruction is significant enough and in particular if there is a predisposition due to genetic factors, obstructive sleep apnoea may also occur. This condition is not only characterized by loud snoring but by obstruction of airflow which in turn leads to significant interruptions of sleep and drops in oxygen level. The interrupted sleep can lead to marked daytime sleepiness. If daytime sleepiness does occur and is more severe than might be reasonably expected from hormonal changes alone, the diagnosis of sleep apnoea should be considered.

In the third trimester as many as 15% of woman may also experience a sensation of discomfort, often described as a "creepy crawly" sensation in the legs which leads to a need to move, kick or even get out of bed and walk. This condition also occurs commonly in non-pregnant men and women but there seems to be an increase due to pregnancy. The consequence can range from being slightly annoying to severely disruptive of sleep.

Menstrual Associated Sleep Disorder

Menstrual Associated Sleep Disorder
In recent years the problems with sleep that women may experience have been better appreciated. Women are among the most chronically sleep deprived members of society, with women from age 30-60 averaging just under 7 hours of sleep per night during the week. This is contributed to by a combination of factors, including the multiple roles many women have as wage earner, homemaker and mother. In addition of course, physiological differences due to changing hormone levels add unique issues for women with what we now recognize as an important effect on sleep quality.

Studies have shown that hormonal changes in the menstrual cycle can and do interfere with sleep for an average 2-3 days per monthly cycle. The interference with sleep appears due to a bloated feeling but clearly contributed to by other factors. The most marked disturbance occurs during the first few days of menstruation. An second time of disrupted sleep occurs as progesterone levels fall towards the end of the menstrual cycle. There may be difficulty falling asleep in this time period. The premenstrual period, the last few days before menstruation commences, is also associated with poorer sleep with insomnia common but sometimes hypersomnia or increased daytime sleepiness may also occur.

Stress and Occupational Related Sleep Disorders

Stress and Occupational Related Sleep Disorders
A common precursor and symptom of stress related illness is the disruption of the Sleep-Wake cycle. Psychological Stress for example due to deadlines, examinations or job crisis leads to activation of the sympathetic nervous system and an increased state of arousal. As a result of this heightened arousal, there is inevitably a degree of sleep disruption and insomnia that can lead to a vicious cycle of chronic insomnia. Timely and adequate treatment of the stressors and the associated sleep disturbances is highly effective in preventing the slide into a chronic state of sleep disruption. A combine approach using medication and Cognitive Therapy is proven to reduce the rate of chronic suffering in patients with stress induced sleep disruption.

Medical and Psychiatric Sleep Disorders

Medical and Psychiatric Sleep Disorders
A significant body of knowledge is accumulating on the role of sleep and its disruption in the causes and prognosis of a variety of Medical and Psychiatric Disorders. It is now well established that poor sleep can contribute to dysfunction of the immune system and that in some psychiatric disorders where sleep disruption is prominent, adequate treatment of the sleep disorder may improve prognosis.


Anxiety Disorders
Individuals with chronic Anxiety are recognised by friends, family and colleagues as being 'nervous', 'tense', 'uptight' and 'always been a worrier'. Between 50% and 70% of people with Generalised anxiety Disorder report trouble sleeping and often report difficulty falling asleep because they cannot stop thinking about things at bedtime. There is ample scientific evidence from Polysomnography (PSG) testing to indicate that Anxiety Disorders result in problems of falling asleep and problems staying asleep. There is also evidence that adequate treatment of the sleep problems in these patients results in improvement of the anxiety symptoms and general functioning.

The American Psychiatric Association's Diagnostic and statistical Manual of Mental Disorders (DSM IV) lists the following core criteria for the diagnosis of Generalised Anxiety Disorder:
1. Excessive Anxiety and worry on most days for at least the past 6 months;
3 The person finds it difficult to control the worry;
3 The worry is associated with at least 3 of the following symptoms

Restlessness or feeling on edge;

Being easily fatigued;
Difficulty concentrating or mind going blank;

Irritability;

Muscle Tension;

Sleep Disturbances including difficulty falling asleep or staying asleep or restless unsatisfying sleep.
For more information on these problems please contact us.


Panic Disorder
The characteristic feature of panic disorder is the recurrent, unexpected occurrence of Panic Attacks that can occur in almost any environment or time of day. These are episodes when a person experiences a high degree of anxiety which is associated with symptoms such as heart palpitations, difficulty breathing, a sense of choking, chest pain, dizziness, feelings of unreality and gastrointestinal disturbances. Patients with Panic disorder frequently report being woken from sleep by a panic attack feeling a sensation of choking and rushing to the nearest window to get some air. These Sleep Panic Attacks occur in up to 70% of people with Panic Disorder.

People with Panic Disorder experience these panic attacks on a frequent basis and as result may become afraid of going to places or situations that they associate with previous panic attacks. At its worst, these people may become totally housebound and unable to work or live according their previous norms. Panic Disorder is three times more common in Women as opposed to men and the average age at which it begins is 22 years.

Sleep complaints by patients with panic disorder include Insomnia, restless, broken sleep, and the more disabling Sleep Panic Attacks or Nocturnal Panic.

The combination of Medical Treatment with Cognitive therapy is highly effective in returning the patient to a normal life.

For more information on these problems please contact us.

Depression
Depression or depressive disorders refer to a constellation of symptoms in which mood related symptoms are the predominant feature.

The core features of Depression are summarised below:
1. Depressed Mood most of the day, nearly everyday, for at least two weeks;
2. Decreased interest or pleasure in almost all daily activities;
3. Insomnia or excessive sleepiness;
4. Significant loss of weight and appetite;
5. Psychomotor Agitation or Retardation;
6. Fatigue and Loss of energy;
7. Feelings of worthlessness or excessive or inappropriate guilt;
8. Decreased ability to concentrate;
9. Preoccupation with Morbid thoughts such as death and dying

More than 80% of patients with depression complain of Insomnia with remainder complaining of excessive sleepiness.

Many patients with Depression report an improvement in their Depressive symptoms after their sleep pattern has returned to normal.

The Sleep Problems in patients with Depression is the most studied of all the psychiatric disorders.

The Sleep Disturbances in Depression are summarised below
1 Problems with the Continuity of Sleep - patients with depression characteristically have a prolonged sleep onset and increased wakefulness during sleep. Early morning waking is also considered a characteristic symptom;
2
Slow-Wave Sleep Deficits - Patients with depression have a decreased amount of Slow-Wave sleep (or deep sleep) especially during the first half of the night;

3 Rapid Eye Movement (REM) sleep abnormalities - The time from falling asleep to the onset of REM sleep is reduced in patients with depression - this decrease in REM onset latency is one of the most robust findings in depression. Other abnormalities of REM sleep include a longer duration of the first REM period, an increased number of rapid eye movements (REM Density) and an overall increase in the percentage of REM sleep
For more information on these problems please contact us.


Dementia
The term Dementia refers to a group of illnesses that have as their essential feature loss of memory associated with degeneration of the brain. The most frequent type of Dementia is Alzheimer's Disease. Other causes of Dementia are Parkinson's Disease, Huntington's Disease, Fatal Familial Insomnia and vascular or Multi-Infarct Dementia.

The following Sleep Disorders occur frequently in patients with Dementia:

1. Sleep Apnoea
2. Sundowning - a state similar to delirium that occurs in the early evening
3. Sleep Disruption at night
4. REM Sleep Dyscontrol
5. Forced Awakenings from Sleep
6. Disturbances of the Circadian/Biological Clock

Chronic Fatigue Syndrome

Chronic Fatigue Syndrome
The Chronic Fatigue Syndrome (CFS) is characterised by the sudden onset of an infectious-type illness, the subsequent chronic and debilitating fatigue, and postexertional malaise; many patients also have recurrent fevers, pharyngitis, adenopathy, myalgias, sleep disorders, and cognitive impairment. Up to 70% of patients with CFS complain of sleep disruption and unrefreshing sleep. This has now been objectively demonstrated through the use of Polysomnogram sleep studies that have demonstrated decreased sleep efficiency and intrusion of the wakeful state into deep sleep in a significant proportion of these patients. There is some evidence that patients with CFS have a deficit in slow Wave sleep called the alpha-delta phenomenon.

Sleep and Activity Disorders of Childhood

Sleep and Activity Disorders of Childhood
Sleep problems are common in childhood. A distinction is made between problems in which polysomnography (PSG) is abnormal (i.e., the parasomnias, sleep apnoea and narcolepsy) and problems that are behavioural in origin and have normal polysomnography.

The parasomnias-sleep terrors, somnambulism and enuresis-appear to be related to central nervous system immaturity and are often outgrown. Obstructive sleep apnoea syndrome (OSAS) is frequently missed in children and can often be cured through surgery.

Behavioural sleep problems may be overcome after parents make interventions.
Physicians and Therapists can be of great assistance to these families by recommending techniques to parents that have been shown to be effective.

The most commonly encountered childhood sleep disorders are:

Nightmares
For most children dreams are pleasant experiences of everyday events. Whilst nightmares are infrequent, often very real, and soon forgotten, for some children they are very disturbing, particularly if frequent or the child dwells on them for several days for example by repetitive acting out of the nightmare with toys; a dread of sleep; struggling to stay awake. So the impact of nightmares should be weighed up with the effect these have on the child's life in general.

Sleep Paralysis
Paralysis can occur in children when they wake up suddenly out of a nightmare and find that they can not move or call out for their parents. The motor inhibition of REM sleep is still active, and may take from seconds to minutes to lift; all the sufferer can do is to breathe, move the eyes and possibly, moan. This is alarming and adds to the child's distress, especially if the dream imagery continues into this wakefulness, as can happen. Younger children may have difficulty in explaining these events and this adds to the parents' concern. Such experiences, which have a neurological basis, usually remit by early adolescence. True familial sleep paralysis is much rarer, and typically happens at sleep onset and/or on awakening, and may well be a symptom of narcolepsy, although, it can occur in isolation. However, narcolepsy seldom appears before adolescence. Both forms of sleep paralysis can often be terminated prematurely by sustained voluntary eye-movement or, if possible, by touch from someone else.

REM Sleep Behaviour Disorder
During REM sleep voluntary muscle are paralysed in order to stop dreams being enacted. In rare circumstances, the paralysis is absent, and if a dream is violent, then harm may come to the sleeper and nearby persons. Although these behaviours are usually correctly diagnosed by patients or their parents, as violent nightmares, they are misunderstood. This disorder has been more frequently reported in adults, but has been found in children. More careful examination usually discloses hindbrain lesions of REM sleep control mechanisms. The most effective treatment is by drugs which suppress REM sleep and psychotherapy such as Hypnosis or Acupuncture.

Sleepwalking
When children are forcibly roused out of stage 2 sleep, a lighter form of non-REM sleep, "thinking" is often reported, which contrasts with the gross visual imagery, unrealism, and more vivid actions of dreaming usually found (but not wholly) in REM sleep. Such thinking is less prevalent in SWS. Sometimes, more disturbing mental events can occur during SWS, with the most notable being sleepwalking (somnambulism) and night terrors (pavor nocturnes), with the latter being quite distinct from the nightmares of dreaming sleep.

These SWS phenomena can be found together. They mainly occur in childhood and tend have some hereditary basis. Sleepwalking peaks in adolescence, but declines rapidly by the late teens. Episodes are often triggered by anxiety; in susceptible children, the worry can be trivial - the loss of a favourite toy, or just a frustrating day. Only in serious cases, when sleepwalking occurs most nights, might there be severe distress and underlying emotional conflict, requiring intervention.

Children are particularly difficult to arouse from SWS, and even very loud sounds of 123 dB can have no effect. It is difficult to wake up a sleepwalking child, and is unwise to do so, as distress or a wild and emotional outburst may set in. It is best to guide or carry them back to bed. As many sleepwalking episodes occur within the first two hours of sleep (when SWS is most prolific), parents are usually still up.

The mind of a sleepwalker is unresponsive to what is going on around and seems steeped in thought. The sleepwalker behaves like an automaton with a limited repertoire of behaviour, but does not walk about with the hands out in front, as is commonly portrayed. There is no memory of the nocturnal activities the next day. Episodes can last up to 30 minutes, but usually average 5-15 minutes.

Sleep EEG recordings of sleep walkers show that they usually remain in SWS whilst sleepwalking, with few signs of arousal. Typically, in a sleepwalking episode the child will sit up quietly, get out of bed and move about in a confused and clumsy manner. Although behaviour becomes more coordinated, the sleepwalker tends to remain in the bedroom, often preoccupied by searching for something in drawers, cupboards or under the bed. It is almost impossible to attract their attention; however, if left alone they normally go back to bed. Navigation is done mostly by memory of the layout of the room and house; the eyes are unseeing and usually it is dark. If the sleepwalker is asked to repeat the act the next day, in wakefulness and blindfolded, then he or she will soon come to grief as recall of the houshold layout is now poor, but somehow heightened during sleep. Difficulties and sometimes injuries occur to sleep-walkers at night if they think they are somewhere else, when walls, doors, staircases and windows are not where they should be.

Night Terrors
These are another phenomenon of deep sleep (SWS) and are sometimes associated with sleep-walking. They are quite distinct from the visually vivid, prolonged nightmare, and are not just bad dreams, but sudden and horrifying sensations accompanying fleeting mental images that shock the sleeper into immediate wakefulness. Night-terrors are also more common in older children than in adults, where, in the latter, the problem is more serious. Typically, the child sits abruptly up in bed, screams and appears to be staring wide-eyed at some imaginary object - maybe "a monster". When this part of the episode passes the child appears to awaken somewhat but is confused and disoriented. They may well remain like this for many minutes until sleep returns, having little or no recollection of the event next morning.

Night terrors can be combined with sleepwalking, particularly in adolescence, when the terrified child may run around the house in an inconsolable and incommunicable state for many minutes; half an hour or more is not uncommon. Again, morning recollection is fragmentary at best.

Toothgrinding
Bruxism is a minor disorder usually found in stages 1 and 2 sleep, and has a tendency to be related to anxiety and/or stressing days. It can occur in children soon after the first dentition has erupted and may lead to tooth damage and misalignment. For this reason a night-time rubber mouthguard is often used. If anxiety is indicated, then relaxation treatments can be successful.

ADHD
More recently there has been an increasing interest in the role of sleep in children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Difficulty falling asleep, restless sleep, night waking, and early morning waking are frequently reported in patients with ADHD. Some professionals now regard sub-groups of these patients as having a primary sleep disorder. More than 40% of patients with ADHD report significant sleep disturbance including insomnia and parasomnias. There is also evidence that inadequate sleep can cause ADHD-like symptoms in some children. Sleep loss in children results in symptoms of inattention, irritability, distractibility and impulsiveness - the core features of ADHD. The evaluation of sleep and activity through the use of Actigraphy is now recommended as a part of the diagnostic workup of children with symptoms of inattention and impulsiveness.

The relationship between ADHD and sleep is complex and requires further research. It is precisely for this reason that the Sleep Medicine group of sleep centres is about to embark on a research project to objectively measure sleep parameters in patients with ADHD.

Circadian Rhythm Disorders

Circadian Rhythm Disorders
The human body functions according to a circadian rhythm thought to be controlled by a biological clock located in the part of the brain called the hypothalamus. There are several distinct disorders of our circadian rhythm and these are listed below:

1. Jet Lag
2. Shift Work related circadian disorder
3. Delayed Sleep Phase Syndrome
4. Advanced Sleep Phase Syndrome
5. Irregular Sleep-Wake Cycle

Sleep Walking and Sleep Terrors

Sleep Walking and Sleep Terrors
Sleepwalking or Somnambulism refers to recurrent episodes of abnormal, complex behavior that occurs during Slow Wave Sleep that is during the first third of the night during stages 3 and 4 of Non REM sleep.

The subject typically leaves the bed and is active in a confused and disoriented state, often moving slowly and clumsily, possibly with injury to themselves. The sleep walking may be preceded by a scream or occurrence of a Sleep Terror, with marked autonomic hyperactivity such as increased heart rate and respiratory rate. When occurring in a state of terror, the movements may be much more rapid, with episodes of rushing into walls, through windows and out into street. There is reduced responsiveness, but the subject may shout or scream. The flight response may include complex behavior such as starting a car and driving. The complex behaviour may be one of escape or of defense against a perceived threat. In some instances trying to stop the subject often leads to violent movements. Although there is amnesia of the event, the subject may have memory of the imminent danger or specific threats against themselves, family or property.

There is often a history of sleepwalking or night terrors in childhood and it is not uncommon for family members to be affected.

Sleepwalking is diagnosed through a combination of history and sleep studies including Actigraphy and PSG.

There are safe and effective treatments available including tablets and psychotherapies such as hypnosis.

REM Sleep Behaviour Disorder

REM Sleep Behaviour Disorder
REM Sleep Behaviour Disorder (RBD) is characterized by vigorous sleep behaviors which may result in repeated injury to oneself or others. These behaviours are often violent and occur during the period of sleep called Rapid Eye Movement or REM sleep. Normally during this phase of sleep, we dream and our muscles are usually without any tone. However, in RBD, there is no loss of this muscle tone and patients usually are able to move their bodies and thereby act on their dreams.

REM sleep behavior disorder (RBD) is characterized by episodes of vigorous speech or shouting, and violent movement or behaviour. It may cause injury to the self or to the bed partner. Dream recall is vivid and the dream content is often violent. Polysomnography is useful in disclosing the violent episodes occurring only during REM sleep. However, this disorder is often misdiagnosed and has not frequently been reported in the United Kingdom

Restless Legs Syndrome

Restless Legs Syndrome
Restless legs syndrome (RLS) is a common yet under-diagnosed movement disorder that is characterized by unpleasant limb sensations occurring at rest and is associated with an irresistible urge to move.

Periodic limb movements (PLM) may accompany these sensations and often interfere with sleep onset or sleep quality. Discomfort, sleep disturbances, and fatigue are direct results of RLS and may have a negative impact on a person's quality of life.

Although RLS was first recognized several centuries ago, it was not until recently that progress began in defining the clinical features of RLS. Specifically, an International RLS Study Group, (the IRLSSG), has organized and has started to define the characteristic symptoms of RLS.

Criteria for the diagnosis of RLS, as described by the IRLSSG, include four features:

An urge to move the legs usually accompanied or caused by uncomfortable and unpleasant sensations in the legs. (Sometimes the urge to move is present without the uncomfortable sensations and sometimes the arms or other body parts are involved in addition to the legs.)
The urge to move or unpleasant sensations begin or worsen during periods of rest or inactivity such as lying or sitting.
The urge to move or unpleasant sensations are partially or totally relieved by movements, such as walking or stretching, at least as long as the activity continues.
The urge to move or unpleasant sensations are worse in the evening or night than during the day or only occur in the evening or night. (When symptoms are very severe, the worsening at night may not be noticeable but must have been previously present.)
Epidemiologic studies have indicated that 5% to 15% of the adult population may experience RLS symptoms.
RLS is easily diagnosed by Actigraphy and PSG studies. No single therapy has been globally approved for the treatment of RLS. Germany and Switzerland are the only countries with an approved treatment available specifically for RLS. A number of treatments have been used off label in the UK, including levodopa, dopamine agonists, benzodiazepines, opioids, and anticonvulsants.

RLS may also occur as part of another disease or illness and may be the first sign of these. This type of RLS is called secondary RLS and occurs in people with Diabetes, Parkinson's disease, Rheumatoid Arthritis, Iron Deficiency Anaemia, in Pregnancy, Neurological diseases and some drugs may cause RLS.

The Sleep Medicine group of sleep centres is actively involved in Research in RLS

Insomnia

Insomnia
Insomnia is an experience of inadequate or poor quality sleep characterized by one or more of the following:
difficulty falling asleep
difficulty maintaining sleep
waking up too early in the morning
nonrefreshing sleep

Insomnia also involves daytime consequences such as:
tiredness
lack of energy
difficulty concentrating
irritability
As many as one-third of patients seen in the primary care setting may experience occasional difficulties in sleeping, and 10 percent of those may have chronic sleep problems.

About 30 to 40 percent of adults indicate some level of insomnia within any given year, and about 10 percent to 15 percent indicate that the insomnia is chronic and/or severe. The prevalence of insomnia increases with age and is more common in women.

Types of Insomnia
Acute Insomnia: Periods of sleep difficulty lasting between one night and a few weeks are referred to as acute insomnia. Acute insomnia is often caused by emotional or physical discomfort. Some common examples include significant life stress; acute illness; and environmental disturbances such as noise, light, and temperature. Sleeping at a time inconsistent with the daily biological rhythm, such as occurs with jet lag, also can cause acute insomnia.

Chronic insomnia refers to sleep difficulty at least three nights per week for one month or more. Chronic insomnia can be caused by many different factors acting singly or in combination, and often occurs in conjunction with other health problems. In other cases sleep disturbance is the major or sole complaint, and involves abnormal sleep-wake regulation or physiology during sleep.

Insomnia associated with psychiatric, medical and neurological disorders. Although psychiatric disorders are a common source of chronic insomnia, they account for less than 50 percent of cases. Mood and anxiety disorders are the most common psychiatric diagnoses associated with insomnia. Insomnia can also be associated with a wide variety of medical and neurological disorders. Factors that cause problems throughout the day such as pain, immobility, difficulty breathing, dementia, and hormonal changes associated with pregnancy, peri-menopause, and menopause can also cause insomnia. Many medical disorders worsen at night, either from sleep per se, circadian influence (e.g., asthma), or lying down (e.g. gastro-oesophageal reflux).

Insomnia associated with medication and substance use. A variety of prescription drugs, non-prescription drugs, and drugs of abuse can lead to increased wakefulness and poor-quality sleep. The likelihood of any given drug contributing to insomnia is unpredictable and may be related to dose, lipid solubility, individual genomic differences, and other factors. Some drugs commonly related to insomnia are stimulating antidepressants, steroids, decongestants, beta blockers, caffeine, alcohol, nicotine, and recreational drugs such as Ecstasy.

At the Sleep Medicine group of sleep centres we offer a specialised treatment service for patients who have insomina associated with substance abuse please contact us for further information.

Insomnia associated with specific sleep disorders. Insomnia can be associated with specific sleep disorders, including restless legs syndrome (RLS), periodic limb movement disorder (PLMD), sleep apnoea, and circadian rhythm sleep disorders.

Primary Insomnia: When other causes of insomnia are ruled out or treated, remaining difficulty with sleep may be classified as primary insomnia. Factors such as chronic stress, hyper-arousal, poor sleep hygiene, and behavioural conditioning may contribute to Primary Insomnia.

Sleep disorders




Sleep accounts for approximately one third of our lives, and a growing number of physicians believe that it should receive more attention from the medical community. Researchers have linked sleep-related illnesses to hypertension, stroke, congestive heart failure, depression, and an overall decreased quality of life.

At the Sleep Medicine group of sleep centres our expertise lies in the Diagnosis and Treatment of the following Sleep and Sleep Related Disorders:

Insomnia
Narcolepsy and Excessive Daytime Sleepiness
Obstructive Sleep Apnoea (OSA)
Restless Legs Syndrome
REM Sleep Behaviour Disorder
Sleep Walking and Sleep Terrors
Circadian Rhythm Disorders
Sleep and Activity Disorders of Childhood including ADHD
Chronic Fatigue Syndrome
Medical and Psychiatric Sleep Disorders
Anxiety Disorders
Panic Disorder
Depression
Dementia and Memory Disorders
Stress and Occupational Related Sleep Disorders
Menstrual Associated Sleep Disorder
Sleep Disorders in Pregnancy and the Postpartum Period

Sleep Apnoea causes Diabetes

Sleep Apnoea causes diabetes - its that simple